Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?

Alzheimers Dement. 2009 Mar;5(2):147-8. doi: 10.1016/j.jalz.2009.01.007.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Age of Onset
  • Aged
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / physiopathology
  • Alzheimer Disease / prevention & control*
  • Biomedical Research / standards
  • Biomedical Research / trends
  • Clinical Trials as Topic / methods
  • Clinical Trials as Topic / standards
  • Cognition Disorders / drug therapy*
  • Cognition Disorders / physiopathology
  • Disease Management*
  • Disease Progression
  • Drug Design
  • Early Diagnosis
  • Humans
  • Outcome Assessment, Health Care / methods
  • Outcome Assessment, Health Care / standards
  • Risk Reduction Behavior*